Clinical Trial: Molecular Breast Imaging (MBI)-Guided Biopsy

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07114679) titled 'Molecular Breast Imaging (MBI)-Guided Biopsy' on Aug. 03.

Brief Summary: The goal of this pilot clinical trial is to demonstrate supplemental screening MBI (molecular breast imaging) in women with dense breasts. The main questions it aims to answer are:

* Does screening MBI find more cancer than screening DBT (3D mammography, digital breast tomosynthesis?

* Does screening MBI result in more call-backs for biopsy than DBT?

* How well does MBI-guided biopsy conform with pathology reports?

Researchers will compare screening MBI to screening DBT to see if MBI is more sensitive to detecting cancer in women with dense breasts.

Partic...